Co-founder, Board Chair


Carolyn is Board Chair and co-founder for BioPharma Global.  A graduate of Kansas State University, she is Founding Board Chair of the Washington Women’s Leadership Initiative (, a board member at The Girl Scout Council of the National Capital Area and My Sister’s Place in Washington, DC. As Principal of Merito Group, Carolyn leads a team of talent acquisition professionals providing client services to a wide range of industries including Big 4, Fortune 1000 companies and small business owners alike.

She is frequently called upon by national news organizations such as The Washington Post, The Wall Street Journal, NPR, CNN, MSNBC, and AOL Jobs among others to contribute content on a variety of topics. A creative entrepreneur and a credentialed career coach, she is regularly published on topics relating to employment, careers, job search, business strategy, social media, organizational and professional development and executive recruiting in various national magazines, trade journals, and on the Internet.

She is a frequent speaker on a national level and has received rave reviews as an engaging and enthusiastic presenter on a variety of topics as a member of the National Speakers Association. An alumnus of Kansas State University, Carolyn is the author of TEN EASY STEPS TO A PERFECT RESUME, TEN STEPS TO FINDING THE PERFECT JOB, and TEN SECRETS TO GETTING PROMOTED available on Carolyn’s blog can be found here.



Co-founder, Chief Executive Officer 


James LaFlamme is the Chief Executive Officer and co-founder of Biopharma Global. He has more than 30 years of healthcare operational experience and has held a variety of senior positions including Chief Executive Officer, Chief Operations Officer, Vice President of Clinical Services, and Administrative Director at several hospitals and health systems. In his current role as Chief Executive Officer he is responsible for leading global operations for BioPharma Global.  This encompasses overseeing the development and delivery of all advisory opinions and client deliverables as well as a full complement of Client Development activities on a worldwide basis.

Prior to joining BPG, he was Executive Vice President at Coté Orphan where he oversaw all aspects of regulatory affairs and business development globally.  Previously, he was Vice President for Accreditation and Recognition Operations at the National Committee for Quality Assurance (NCQA) where he was responsible for the delivery of NCQA’s nine accreditation and certification programs and three physician recognition programs. Earlier in his career he was the Director of the Healthcare Advisory Public Sector Practice at PricewaterhouseCoopers (PwC). At PwC, his primary focus was improving clinical and business operations for key healthcare clients.

James earned a BS degree in Pharmacy from the University of Connecticut School of Pharmacy and a MS degree in Management from Indiana Wesleyan University. He serves on the Deans Advisory Board at the UCONN School of Pharmacy and is a Fellow of the American College of Healthcare Executives.



Chief Science Officer 


Dr. Sandra Heibel is the Chief Science Officer for BioPharma Global. In her current role, Sandi is responsible for all client deliverables and advisory opinions. Sandi has worked with Haffner Associates and is the Principal at Heibel Consulting LLC. She has an extensive knowledge of drug development research for rare diseases, regulatory strategy, scientific writing, regulatory submissions, and project management. Sandi also serves as a Project Manager for Scientific Operations at BioPontis Alliance for Rare Diseases, a non-profit corporation dedicated to the development of new therapeutic agents to treat rare diseases. She has a Bachelor’s in Animal Bioscience from Penn State University and completed her Master’s and PhD at the University of Maryland where she studied the molecular biology of rare heritable diseases of metabolism. Through her doctoral experience and as part of a scientist-clinician team, she identified and characterized disease-causing mutations in patients with ultra-rare diseases, assisted with clinical studies, and learned about the need and value of developing drugs for rare diseases.




Client Development Manager


Dr. Thomas Ng has 20 years of biotech experience on both the science and business side of the industry. He currently functions as the Client Development Manager and is a key member of the management team at BioPharma Global. In his current role, he is responsible for leading all client development activities on a worldwide basis. Prior to joining BPG, he has held management level positions including R&D, Program/Project Management, Alliance/Channel Management, Marketing & Sales and Business Development, on a both national and international basis while working at various biotechnology companies along the I-270 tech corridor of Maryland, including Celera, Gene Logic and BioReliance and more recently worked in the preclinical services arena with Noble Life Sciences and Epistem. Dr. Ng’s academic background includes a BS in Biochemistry from the University of Maryland and a PhD in Molecular Biology from Johns Hopkins University. He is also an Executive Board Member and President Emeritus of the CMNS Alumni Association Chapter at the University of Maryland.